Skip to main content
Caplight Logo









i-SEP

i-SEP

Private
NantesHealthcare & Life Scienceshttps://www.i-sep.com/

Last Round

VC Round

Jan 14, 2026

Est. Valuation

$8.72M

Total Funding Raised

$4.89M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

i-SEP is a biotechnology company that develops and markets innovative intraoperative autotransfusion and Patient Blood Management solutions for hemorrhagic surgeries.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Non-AI

Keywords

intraoperative autotransfusioncell salvagepatient blood managementPBMIOCSmedical deviceblood recoverysurgical blood managementautotransfusion systemmedtechblood separation technologyplatelet recoverysingle-use consumablesblood conservationbloodless surgery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

i-SEP Comparables

Compare i-SEP with similar companies based on industry and business-model similarity.

i-SEP comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Tecnoline S.p.A.
78%
Brightwake Ltd
78%
Fresenius SE & Co. KGaA
76%

i-SEP Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJan 14, 2026
VC RoundSep 26, 2019
GrantOct 23, 2018
VC RoundMay 4, 2017
SeedOct 28, 2015

i-SEP Investors

Notable investors and investment history

i-SEP investors
InvestorRounds
GwenneGVC Round
GO CapitalVC Round, Seed
WiSeedVC Round
BpifranceGrant
Région Pays de la LoireGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 23, 2026

    Monthly visitors increased 65% MoM.

  • May 16, 2026

    Monthly visitors increased 387% MoM.

i-SEP Filings

Explore SEC and related filing metadata, where available.

i-SEP filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about i-SEP's valuation, stock price, and market status.

Is i-SEP a public or private company?

i-SEP is a private company.

What is the current stock price of i-SEP?

i-SEP is a private company with no public stock price. Caplight tracks i-SEP's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is i-SEP worth (valuation)?

i-SEP's valuation is estimated at $8.7M based on funding round data.

Can I buy i-SEP stock?

i-SEP shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was i-SEP's last funding round?

i-SEP's most recent funding round was VC Round on January 14, 2026.

Who are the main investors in i-SEP?

Key investors in i-SEP include GO Capital.

Will i-SEP IPO soon?

No public IPO plans have been announced for i-SEP.

How can I track i-SEP secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor i-SEP's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNantes
Employee Range30
Year Founded2015
Last FundingJan 14, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?